{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:49:25Z","timestamp":1793504965945,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.pnpbp.2005.08.014","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T11:21:02Z","timestamp":1129634462000},"page":"273-279","source":"Crossref","is-referenced-by-count":13,"title":["The effect of chronic administration of sarizotan, 5-HT1A agonist\/D3\/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia"],"prefix":"10.1016","volume":"30","author":[{"given":"Helen","family":"Rosengarten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd D.","family":"Bartoszyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Quartermain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2005.08.014_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002130100767","article-title":"Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration","volume":"157","author":"Andreassen","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib2","first-page":"530","article-title":"Pharmacological profile of EMD 128130: A putative atypical antipsychotic with dopamine D2 antagonistic and serotonin 5-HT1A agonistic properties","volume":"23","author":"Bartoszyk","year":"1997","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00702-003-0094-7","article-title":"Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand: 1. Neurochemical profile","volume":"111","author":"Bartoszyk","year":"2004","journal-title":"J. Neural Transm."},{"issue":"suppl. 10","key":"10.1016\/j.pnpbp.2005.08.014_bib4","first-page":"13","article-title":"Safety of olanzapine","volume":"58","author":"Beasley","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/WNL.57.10.1829","article-title":"Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models","volume":"57","author":"Bibbiani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002826-199402000-00008","article-title":"Buspirone in levodopa-induced dyskinesias","volume":"17","author":"Bonifati","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00174869","article-title":"Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine","volume":"338","author":"Broekkamp","year":"1988","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajmg.b.10004","article-title":"Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia","volume":"116","author":"Chong","year":"2003","journal-title":"Am. J. Med. Genet., B Neuropsychiatr. Genet."},{"issue":"suppl. 1","key":"10.1016\/j.pnpbp.2005.08.014_bib9","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1097\/00004714-199502001-00007","article-title":"Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study","volume":"15","author":"Chouinard","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0893-133X(97)00176-0","article-title":"Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers","volume":"18","author":"Christoffersen","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(79)90499-0","article-title":"Changes in dopamine-mediated behaviour during one year's neuroleptic administration","volume":"57","author":"Clow","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0028-3908(75)90114-8","article-title":"Serotonergic involvement with neuroleptic catalepsy","volume":"14","author":"Costall","year":"1975","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0306-4522(95)00548-X","article-title":"A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia","volume":"72","author":"Eberle-Wang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/syn.890180303","article-title":"Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias","volume":"18","author":"Egan","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002130050095","article-title":"Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol","volume":"127","author":"Egan","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8","article-title":"Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia","volume":"96","author":"Eichhammer","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00177570","article-title":"Chronic neuroleptics alter the effects of D1 agonists SK&F38393 and the D2 agonist LY 171555 on oral movements in rats","volume":"96","author":"Ellison","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-8993(97)00242-4","article-title":"Single restrain stress sensitizes acute chewing movements induced by haloperidol, but not if the 5HT1A agonist 8-OH-DPAT is given prior to stress","volume":"755","author":"Espejo","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.7100929","article-title":"Amphetamine, haloperidol and experience interact with effect of recovery after motor cortex injury","volume":"217","author":"Feeney","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0024-3205(90)90198-Z","article-title":"Effect of a dopamine D-1 agonist in rats treated chronically with zuclopenthixol","volume":"47","author":"Glenthoj","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib22","first-page":"1000","article-title":"Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system","volume":"261","author":"Gong","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0024-3205(90)90365-X","article-title":"The effect of serotonergic agents on haloperidol-induced catalepsy","volume":"47","author":"Hicks","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(99)02346-X","article-title":"The effect of serotonin 1A receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens","volume":"858","author":"Ichikawa","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s007020050234","article-title":"Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia","volume":"106","author":"Ikeda","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0028-3908(88)90134-7","article-title":"8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis","volume":"27","author":"Invernizzi","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.mp.4000262","article-title":"Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: a new twist on dyskinesias?","volume":"2","author":"Jeste","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(87)90134-8","article-title":"Opposite effects of D1 and D2 agonist on oral movements in rats","volume":"134","author":"Johansson","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib29","first-page":"254","article-title":"Integrating incidence and prevalence of tardive dyskinesia","volume":"22","author":"Kane","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D2 occupancy, clinical response and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib31","first-page":"803","article-title":"Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons","volume":"253","author":"Kelland","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jnnp.54.4.376-a","article-title":"Buspirone in the treatment of levodopa induced dyskinesias","volume":"54","author":"Kleedorfer","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(94)90081-7","article-title":"Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements","volume":"646","author":"Knable","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF02245460","article-title":"Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats","volume":"114","author":"Kulikov","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib35","article-title":"Differential effects of sarizotan on dopamine receptor function","volume":"30","author":"Kuzhikandathil","year":"2004","journal-title":"Soc. Neurosci. Abstr. Online"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0893-133X(02)00293-2","article-title":"Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism","volume":"27","author":"Lerer","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/BF00439547","article-title":"Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction","volume":"97","author":"Liebman","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0028-3908(03)00282-X","article-title":"Contribution of the serotonin 5-HT1A receptor agonism of 8-OH-DPAT and EMD 128130 to the regulation of haloperidol-induced muscle rigidity in rats","volume":"45","author":"Lorenc-Koci","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00002826-199212000-00002","article-title":"Effect of D1 and D2 agonists in primates withdrawn from long term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia","volume":"15","author":"Lublin","year":"1992","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","article-title":"8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release","volume":"131","author":"Lucas","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0091-3057(93)90375-4","article-title":"Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat","volume":"46","author":"Luminga","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib42","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1523\/JNEUROSCI.20-20-07798.2000","article-title":"Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic induced dyskinesia","volume":"20","author":"Meredith","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(89)90093-9","article-title":"The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D1:D2 interaction","volume":"160","author":"Murray","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(01)00986-4","article-title":"Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists","volume":"420","author":"Naidu","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(01)01284-5","article-title":"Effect of 5HT1A and 5HT2A\/2C receptor modulation on neuroleptic-induced vacuous chewing movements","volume":"428","author":"Naidu","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib46","first-page":"207","article-title":"Serotonergic involvement in haloperidol-induced catalepsy","volume":"265","author":"Neal-Beliveau","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1358\/mf.1999.21.9.795610","article-title":"Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics","volume":"21","author":"Ninan","year":"1999","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00002826-200403000-00003","article-title":"Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)","volume":"27","author":"Olanow","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib49","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0006-8993(00)02017-5","article-title":"No changes in dopamine D1 receptor mRNA expressing neurons in the dorsal striatum of rats with oral movements induced by long-term haloperidol administration","volume":"859","author":"Petersen","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib50","first-page":"615","article-title":"Dorsal raphe nucleus lesions have no effect on neuroleptic-induced catalepsy and on the anticataleptic activity of buspirone","volume":"24","author":"Pires","year":"1991","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib51","first-page":"323","article-title":"Influence of median raphe nucleus lesions on neuroleptic-induced catalepsy and on the anticataleptic effect of buspirone","volume":"26","author":"Pires","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(02)02430-5","article-title":"5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy","volume":"453","author":"Prinssen","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0024-3205(97)00394-9","article-title":"Effects of buspirone on dopaminergic supersensitivity","volume":"61","author":"Queiroz","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib54","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0278-5846(99)00074-3","article-title":"Effects of buspirone on an animal model of tardive dyskinesia","volume":"23","author":"Queiroz","year":"1999","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1098-2396(20010101)39:1<8::AID-SYN2>3.0.CO;2-K","article-title":"Effect of chronic olanzapine treatment on striatal synaptic organization","volume":"39","author":"Roberts","year":"2001","journal-title":"Synapse"},{"issue":"suppl. 1","key":"10.1016\/j.pnpbp.2005.08.014_bib57","first-page":"S440","article-title":"The effect of the D3 dopamine receptor antagonist GR 103.691 in rat model of tardive dyskinesia","volume":"7","author":"Rosengarten","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib56","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/0024-3205(83)90155-8","article-title":"Induction of oral dyskinesias in na\u00efve rats by D1 stimulation","volume":"33","author":"Rosengarten","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0024-3205(86)90434-0","article-title":"Selective D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats","volume":"39","author":"Rosengarten","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4899-2723-1_11","article-title":"Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements","volume":"235","author":"Rosengarten","year":"1988","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib60","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0278-5846(99)00073-1","article-title":"The effect of novel antipsychotics in rat oral dyskinesia","volume":"23","author":"Rosengarten","year":"1999","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0166-4328(97)00092-2","article-title":"Regional brain changes in [3H]SCH 23390 binding to dopamine D1 receptors after long-term haloperidol treatment: lack of correspondence with the development of vacuous chewing movements","volume":"90","author":"Sasaki","year":"1998","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mp.4000249","article-title":"Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients","volume":"2","author":"Steen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib63","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0028-3908(93)90069-F","article-title":"Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects","volume":"32","author":"Svensson","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib64","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF02247127","article-title":"Neuroleptic induced vacuous chewing movements as an animal model of TD: a study in three rat strains","volume":"102","author":"Tamminga","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00213-002-1259-z","article-title":"The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats","volume":"165","author":"Turrone","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-6147(99)01432-7","article-title":"5-HT7 receptors: current knowledge and future prospects","volume":"21","author":"Vanhoenacker","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4522(00)00412-7","article-title":"Dopamine D1A receptor function in a rodent model of tardive dyskinesia","volume":"101","author":"Van Kampen","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/358149a0","article-title":"Multiple dopamine D4 receptor variants in the human population","volume":"358","author":"Van Tol","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.6132447","article-title":"Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment","volume":"220","author":"Waddington","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0149-7634(95)00057-7","article-title":"Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat","volume":"20","author":"Wadenberg","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0028-3908(95)00013-V","article-title":"Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat","volume":"34","author":"Wadenberg","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.08.014_bib73","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0091-3057(94)90152-X","article-title":"Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat","volume":"47","author":"Wadenberg","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.tpj.6500152","article-title":"Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans","volume":"3","author":"Werge","year":"2003","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1440-1819.2002.01038.x","article-title":"Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics","volume":"56","author":"Woo","year":"2002","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2005.08.014_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1098-2396(19991201)34:3<192::AID-SYN4>3.0.CO;2-L","article-title":"Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol","volume":"34","author":"Yu","year":"1999","journal-title":"Synapse"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605002770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605002770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T03:59:33Z","timestamp":1683259173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584605002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0278584605002770"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.08.014","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}